Market Research Logo

Mozambique Pharmaceuticals and Healthcare Report Q4 2017

Mozambique Pharmaceuticals and Healthcare Report Q4 2017

BMI View:

The government's sharp cutbacks to spending, in the wake of the so-called hidden debt scandaland subsequent default on its payments, will further impede growth in the country's underdevelopedpharmaceutical and healthcare sectors. The country's high prevalence of diseases coupled with a risingpopulation should support market growth over the coming years, although this will be almost exclusively inthe generic drug segment due to the lack of affordability of other forms of drugs. A continued reliance oninternational funding along with currency volatility and weak infrastructure development will addheadwinds to an already challenging business environment.

Headline Expenditure Forecasts

Pharmaceuticals: MZN8.86bn (USD141mn) in 2016 to MZN9.49bn (USD134mn) in 2017; +7.1% inlocal currency and -4.8% in US dollar terms. Forecast revised upwards in US dollar terms from lastquarter.

Healthcare: MZN40.60bn (USD646mn) in 2016 to MZN43.28bn (USD612mn) in 2017; +6.6% in localcurrency and -5.3% in US dollar terms. Forecast revised upwards in US dollar terms from last quarter.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Mozambique 2015-2021)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Mozambique 2013-2021)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Mozambique 2013-2021)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Mozambique 2013-2021)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Mozambique 2013-2021)
Industry Risk Reward Index
Sub-Saharan Africa Pharmaceuticals: Small Market Sizes Weaken Attractiveness To Innovative Drugmakers
Innovative Pharmaceuticals Risk/Reward Index - Mozambique - Q4 2017
Reward
Risk
Regulatory Review
Regulatory Development
Intellectual Property Issues
Pricing Regime
Market Overview
Healthcare Sector
Clinical Trials
Epidemiology
Competitive Landscape
Research-Based Industry
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Company Profile
Sociedade Moçambicana de Medicamentos (SMM)
Demographic Forecast
Table: Population Headline Indicators (Mozambique 1990-2025)
Table: Key Population Ratios (Mozambique 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Mozambique 1990-2025)
Table: Population By Age Group (Mozambique 1990-2025)
Table: Population By Age Group % (Mozambique 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Table: Indicators - Rationale And Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report